⌘K
Loading ticker…
As of 2026-08-24, Taysha Gene Therapies, Inc. Common Stock (TSHA) has a 3-month relative strength percentile of 65 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 62. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.8%, relative volume 0.92×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TSHA is held by 20 ETFs as of May 2026. Top owner: VTWO at 0.04% weight, $7M notional. Top 3 carry $15M.
Held by 52 ETFs · $152M across latest filings · largest weight 1.53% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.04% | $7M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.03% | $6M | — |
| VHTVanguard Health Care ETF | 0.01% | $2M | — |
| VFMO | 0.11% | $2M | — |
| SBIO | 1.02% | $2M | +0.22 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.07% |
| $1M |
| — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $774K | — |
| ONEQ | 0.00% | $545K | — |
| GSSC | 0.04% | $381K | new |
| GINN | 0.06% | $137K | −0.01 pp |
Showing 10 of 20 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TSHA Jan avg: -18.21% median: -16.06% win: 0% σ: 6.48% n: 4 2022-04-12 → 2026-07-31 | TSHA Feb avg: 19.15% median: 3.55% win: 75% σ: 62.44% n: 4 2022-04-12 → 2026-07-31 | TSHA Mar avg: -11.16% median: -11.15% win: 0% σ: 8.20% n: 4 2022-04-12 → 2026-07-31 | TSHA Apr avg: 5.51% median: -2.83% win: 40% σ: 34.84% n: 5 2022-04-12 → 2026-07-31 | TSHA May avg: 6.51% median: -8.14% win: 40% σ: 32.17% n: 5 2022-04-12 → 2026-07-31 | TSHA Jun avg: 1.40% median: -5.42% win: 40% σ: 30.83% n: 5 2022-04-12 → 2026-07-31 | TSHA Jul avg: 2.83% median: 1.85% win: 60% σ: 12.03% n: 5 2022-04-12 → 2026-07-31 | TSHA Aug avg: 90.33% median: 4.16% win: 75% σ: 190.44% n: 4 2022-04-12 → 2026-07-31 (current) | TSHA Sep avg: -9.61% median: -5.76% win: 25% σ: 21.57% n: 4 2022-04-12 → 2026-07-31 | TSHA Oct avg: -0.27% median: -13.40% win: 25% σ: 35.20% n: 4 2022-04-12 → 2026-07-31 | TSHA Nov avg: 22.75% median: 12.03% win: 50% σ: 50.95% n: 4 2022-04-12 → 2026-07-31 | TSHA Dec avg: -6.93% median: 1.42% win: 75% σ: 27.34% n: 4 2022-04-12 → 2026-07-31 |